Martha Geoffrey 4

What Happened Martha Geoffrey, Medtronic’s Chairman and CEO, had 41,936 shares withheld and disposed to cover tax withholding related to vested performance-restricted stock units. The shares were recorded as disposed on June 4, 2026 at $83.32 per share, for a total value of approximately $3,494,108. This transaction is coded "F" (shares withheld for taxes), a routine action when RSUs settle rather than an open-market sale initiated for investment reasons.

Key Details

• Transaction date and price: June 4, 2026 — 41,936 shares @ $83.32 each (total ~$3,494,108).
• Transaction code: F — shares withheld to satisfy tax withholding obligations on vested awards.
• Footnote: Represents shares withheld for taxes upon settlement of performance-vesting RSUs that vested April 24, 2026.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Filing timeliness: Form 4 filed on June 8, 2026 (within the 2-business-day deadline for a June 4 transaction).

Context This was a tax-withholding disposition tied to the settlement of performance RSUs, not an active open-market sale for cash or investment reasons. Such withholdings are common when equity awards vest and do not necessarily signal a change in the insider’s view of the company.